CVS Looks to Firm Up Expansion

Tags: cvs
4 Dec 11:32pm
Posted by ZacksResearch
0 Comments
Read original blog entry

CVS Caremark Corporation (CVS) is one of the leaders in the domestic drug store industry and the pharmacy services industry.

Management embarked on an aggressive expansion strategy, including the merger of equals with Caremark. There is substantial operational risk concerning the integration of the five significant acquisitions that were closed during the last two years.

Also, generic drug introductions and Wal-Mart's (WMT) entry into the generic drug industry are negatively impacting the profitability of the drug store industry, including CVS Caremark. Therefore, the stock is rated a Hold.

Read the full analyst report on CVS




Get real-time market insights and profitable stock recommendations from the team of analysts at Zacks Equity Research. See all today’s Analyst Blog entries on Zacks.com.

Comments

Back to top

Post comment

Back to top

Post a comment

Please login to post a comment

About

ZacksResearch

Zacks Investment Research is one of the most highly regarded firms in the investment industry. Our firm has long believed that that quantitative models (like the Zacks Rank) can predict stock prices more accurately than individual analysts. However we also recognize that models are most effective when they are employed by analysts who have deep fundamental knowledge of the company and its industry. Consequently Zacks Equity Research combines Zacks quantitative models with the insight provided by an experienced team of 50 analysts to create superior long term stock recommendations. Discover all their timely insight and recommendations daily on Zacks.com.

Recent Entries